Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Home
  • Home
Article
  • Cited by 13

  • Access

Oral Lactobacillus reuteri GMN-32 treatment reduces blood glucose concentrations and promotes cardiac function in rats with streptozotocin-induced diabetes mellitus

  • Chih-Hsueh Lin (a1) (a2) (a3), Cheng-Chieh Lin (a1) (a2) (a3), Marthandam Asokan Shibu (a4), Chiu-Shong Liu (a1) (a2) (a3), Chia-Hua Kuo (a5), Fuu-Jen Tsai (a6), Chang-Hai Tsai (a7), Cheng-Hong Hsieh (a6), Yi-Hsing Chen (a8) and Chih-Yang Huang (a4) (a5) (a6)...
  • Please note a correction has been issued for this article.

Abstract

Impaired regulation of blood glucose levels in diabetes mellitus (DM) patients and the associated elevation of blood glucose levels are known to increase the risk of diabetic cardiomyopathy (DC). In the present study, a probiotic bacterium, Lactobacillus reuteri GMN-32, was evaluated for its potential to reduce blood glucose levels and to provide protection against DC risks in streptozotocin (STZ)-induced DM rats. The blood glucose levels of the STZ-induced DM rats when treated with L. reuteri GMN-32 decreased from 4480 to 3620 mg/l (with 107 colony-forming units (cfu)/d) and 3040 mg/l (with 109 cfu/d). Probiotic treatment also reduced the changes in the heart caused by the effects of DM. Furthermore, the Fas/Fas-associated protein with death domain pathway-induced caspase 8-mediated apoptosis that was observed in the cardiomyocytes of the STZ-induced DM rats was also found to be controlled in the probiotic-treated rats. The results highlight that L. reuteri GMN-32 treatment reduces blood glucose levels, inhibits caspase 8-mediated apoptosis and promotes cardiac function in DM rats as observed from their ejection fraction and fractional shortening values. In conclusion, the administration of L. reuteri GMN-32 probiotics can regulate blood glucose levels, protect cardiomyocytes and prevent DC in DM rats.

  • View HTML

      • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Oral Lactobacillus reuteri GMN-32 treatment reduces blood glucose concentrations and promotes cardiac function in rats with streptozotocin-induced diabetes mellitus
      Available formats
      ×

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Oral Lactobacillus reuteri GMN-32 treatment reduces blood glucose concentrations and promotes cardiac function in rats with streptozotocin-induced diabetes mellitus
      Available formats
      ×

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Oral Lactobacillus reuteri GMN-32 treatment reduces blood glucose concentrations and promotes cardiac function in rats with streptozotocin-induced diabetes mellitus
      Available formats
      ×

Copyright

COPYRIGHT: © The Authors 2013 

Corresponding author

*Corresponding author: C.-Y. Huang, fax +886 4 22032295, email cyhuang@mail.cmu.edu.tw

References

Hide All
1DeFronzo, RA, Bonadonna, RC & Ferrannini, E (1992) Pathogenesis of NIDDM. A balanced overview. Diabetes Care 15, 318–368.
2Gadsby, R (2000) Type 2 diabetes: prediction and prevention. Fam Pract 17, 213–214.
3Haffner, SM, Greenberg, AS, Weston, WM, et al. (2002) Effect of rosiglitazone treatment on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus. Circulation 106, 679–684.
4Manson, JE, Colditz, GA, Stampfer, MJ, et al. (1991) A prospective study of maturity-onset diabetes mellitus and risk of coronary heart disease and stroke in women. Arch Intern Med 151, 1141–1147.
5Storey, AM, Perry, CJ & Petrie, JR (2001) Review: endothelial dysfunction in type 2 diabetes. Br J Diabetes Vasc Dis 1, 22–27.
6Oduru, M & Ahmad, M (2012) Massive levemir (long-acting) insulin overdose: case report. Case Report Med 2012, 904841.
7Kaur, IP, Chopra, K & Saini, A (2002) Probiotics: potential pharmaceutical applications. Eur J Pharm Sci 15, 1–9.
8de Moreno de LeBlanc, A, Matar, C, Perdigon, G, et al. (2007) The application of probiotics in cancer. Br J Nutr 98, Suppl. 1, S105–S110.
9Laitinen, K, Poussa, T, Isolauri, E, et al. (2009) Probiotics and dietary counselling contribute to glucose regulation during and after pregnancy: a randomised controlled trial. Br J Nutr 101, 1679–1687.
10Matsuzaki, T, Yamazaki, R, Hashimoto, S, et al. (1997) Antidiabetic effects of an oral administration of Lactobacillus casei in a non-insulin-dependent diabetes mellitus (NIDDM) model using KK-Ay mice. Endocr J 44, 357–365.
11Matsuzaki, T, Nagata, Y, Kado, S, et al. (1997) Effect of oral administration of Lactobacillus casei on alloxan-induced diabetes in mice. APMIS 105, 637–642.
12Panwar, H, Rashmi, HM, Batish, VK, et al. (2013) Probiotics as potential biotherapeutics in the management of type 2 diabetes – prospects and perspectives. Diabetes Metab Res Rev 29, 103–112.
13Kim, SW, Park, KY, Kim, B, et al. (2013) Lactobacillus rhamnosus GG improves insulin sensitivity and reduces adiposity in high-fat diet-fed mice through enhancement of adiponectin production. Biochem Biophys Res Commun 431, 258–263.
14Akula, A, Kota, MK, Gopisetty, SG, et al. (2003) Biochemical, histological and echocardiographic changes during experimental cardiomyopathy in STZ-induced diabetic rats. Pharmacol Res 48, 429–435.
15Lu, YC, Yin, LT, Chang, WT, et al. (2010) Effect of Lactobacillus reuteri GMNL-263 treatment on renal fibrosis in diabetic rats. J Biosci Bioeng 110, 709–715.
16Yadav, H, Jain, S & Sinha, PR (2007) Antidiabetic effect of probiotic dahi containing Lactobacillus acidophilus and Lactobacillus casei in high fructose fed rats. Nutrition 23, 62–68.
17Al-Salami, H, Butt, G, Tucker, I, et al. (2008) Probiotic pre-treatment reduces gliclazide permeation (ex vivo) in healthy rats but increases it in diabetic rats to the level seen in untreated healthy rats. Arch Drug Inf 1, 35–41.
18Andersson, U, Branning, C, Ahrne, S, et al. (2010) Probiotics lower plasma glucose in the high-fat fed C57BL/6J mouse. Benef Microbes 1, 189–196.
19Huang, CY, Yang, AL, Lin, YM, et al. (2012) Anti-apoptotic and pro-survival effects of exercise training on hypertensive hearts. J Appl Physiol 112, 883–891.
20Lee, SD, Shyu, WC, Cheng, IS, et al. (2013) Effects of exercise training on cardiac apoptosis in obese rats. Nutr Metab Cardiovasc Dis 23, 566–573.
21Lee, SD, Kuo, WW, Ho, YJ, et al. (2008) Cardiac Fas-dependent and mitochondria-dependent apoptosis in ovariectomized rats. Maturitas 61, 268–277.
22U.S. National Institutes of Health (1984) Laboratory animal welfare; proposed U.S. government principles for the utilization and care of vertebrate animals used in testing, research and training. Fed Regist 49, 29350–29351.
23de Vrese, M & Schrezenmeir, J (2008) Probiotics, prebiotics, and synbiotics. Food Biotechnol 111, 1–66.
24Oxman, T, Shapira, M, Klein, R, et al. (2001) Oral administration of Lactobacillus induces cardioprotection. J Altern Complement Med 7, 345–354.
25Shiomi, T, Tsutsui, H, Ikeuchi, M, et al. (2003) Streptozotocin-induced hyperglycemia exacerbates left ventricular remodeling and failure after experimental myocardial infarction. J Am Coll Cardiol 42, 165–172.
26De Angelis, K, Schaan, BD, Maeda, CY, et al. (2002) Cardiovascular control in experimental diabetes. Braz J Med Biol Res 35, 1091–1100.
27Cheng, SM, Ho, TJ, Yang, AL, et al. (2013) Exercise training enhances cardiac IGFI-R/PI3K/Akt and Bcl-2 family associated pro-survival pathways in streptozotocin-induced diabetic rats. Int J Cardiol 167, 478–485.
28Franz, MJ (2007) The dilemma of weight loss in diabetes. Diabetes Spectr 20, 133–136.
29Gudmundsson, P, Rydberg, E, Winter, R, et al. (2005) Visually estimated left ventricular ejection fraction by echocardiography is closely correlated with formal quantitative methods. Int J Cardiol 101, 209–212.
30He, KL, Burkhoff, D, Leng, WX, et al. (2009) Comparison of ventricular structure and function in Chinese patients with heart failure and ejection fractions >55 % versus 40 % to 55 % versus < 40 %. Am J Cardiol 103, 845–851.
31Regitz-Zagrosek, V, Brokat, S & Tschope, C (2007) Role of gender in heart failure with normal left ventricular ejection fraction. Prog Cardiovasc Dis 49, 241–251.
32Soetikno, V, Sari, FR, Sukumaran, V, et al. (2012) Curcumin prevents diabetic cardiomyopathy in streptozotocin-induced diabetic rats: possible involvement of PKC–MAPK signaling pathway. Eur J Pharm Sci 47, 604–614.
33Kawamori, R, Kadowaki, T & Ishida, H (2004) [Achieving better control of blood sugar – understanding of oral hypoglycemic agents according to their characteristics in pharmacological action mechanism (discussion)]. Nihon Rinsho 62, 831–839.
34Poirier, P, Bogaty, P, Philippon, F, et al. (2003) Preclinical diabetic cardiomyopathy: relation of left ventricular diastolic dysfunction to cardiac autonomic neuropathy in men with uncomplicated well-controlled type 2 diabetes. Metabolism 52, 1056–1061.
35Kuo, WW, Chung, LC, Liu, CT, et al. (2009) Effects of insulin replacement on cardiac apoptotic and survival pathways in streptozotocin-induced diabetic rats. Cell Biochem Funct 27, 479–487.
36Chbinou, N & Frenette, J (2004) Insulin-dependent diabetes impairs the inflammatory response and delays angiogenesis following Achilles tendon injury. Am J Physiol Regul Integr Comp Physiol 286, R952–R957.
37Lopes-Virella, MF & Virella, G (2003) The role of immune and inflammatory processes in the development of macrovascular disease in diabetes. Front Biosci 8, s750–s768.

Keywords

  • Cited by 13

  • Access

Oral Lactobacillus reuteri GMN-32 treatment reduces blood glucose concentrations and promotes cardiac function in rats with streptozotocin-induced diabetes mellitus

  • Chih-Hsueh Lin (a1) (a2) (a3), Cheng-Chieh Lin (a1) (a2) (a3), Marthandam Asokan Shibu (a4), Chiu-Shong Liu (a1) (a2) (a3), Chia-Hua Kuo (a5), Fuu-Jen Tsai (a6), Chang-Hai Tsai (a7), Cheng-Hong Hsieh (a6), Yi-Hsing Chen (a8) and Chih-Yang Huang (a4) (a5) (a6)...
  • Please note a correction has been issued for this article.

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed

A correction has been issued for this article: